A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤35 kg/m2 undergoing roux-en-y gastric bypass

World Journal of Surgery

Volumn 39, Issue 1, 2015, Pages 223-230

  Rao, Wen Sheng ^a   Shan, Cheng Xiang ^a   Zhang, Wei ^a   Jiang, Dao Zhen ^a   Qiu, Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ANALYSIS; BODY MASS; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; HUMAN; LENGTH OF STAY; META ANALYSIS; OPERATION DURATION; REMISSION; STOMACH BYPASS;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LENGTH OF STAY; OPERATIVE TIME; REMISSION INDUCTION;

EID: 84928102110     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2751-4     Document Type: Article

References (43)

1. CadeWT(2008) Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88:1322-1335
2. Pontiroli AE (2012) Cardiovascular events after bariatric surgery. JAMA 307:1577-1578
3. Anjali DD, Marcie HH, Mario S (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254-1264
4. Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753-761
5. Levy P, Fried M, Santini F et al (2007) The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg 17:1248-1256
6. Laferrère B, Teixeira J, McGinty J et al (2008) Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinal Metab 93:2479-2485
7. Castagneto M, Mingrone G (2012) The effect of gastrointestinal surgery on insulin resistance and insulin secretion. Curr Atheroscler Rep 14:624-630
8. 2. J Gastrointest Surg 12:945-952
9. 2: a tailored approach. Surg Obes Relat Dis 2:401-404
10. Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467-484
11. Cremieux PY, Buchwald H, Shikora SA et al (2008) A study on the economic impact of bariatric surgery. Am J Manag Care 14:589-596
12. Flum DR, Dellinger EP (2004) Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199:543-551
13. 2. Obes Surg 21:889-895
14. Huang CK, Shabbir A, Lo CH et al (2011) Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg 21:1344-1349
15. Boza C, Muñoz R, Salinas J et al (2011) Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in nonseverely obese patients. Obes Surg 21:1330-1336
16. DeMaria EJ, Winegar DA, Pate VW et al (2010) Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg 252:559-567
17. 2. Surgery 150:684-691
18. 2. Obes Surg 21:283-287
19. Zhu LY, Mo ZH, Yang XW et al (2012) Effect of Laparoscopic Roux-en-Y gastroenterostomy with BMI <35 kg/m2 in type 2 diabetes mellitus. Obes Surg 22:1562-1567
20. Lanzarini E, Csendes A, Gutierrez L et al (2013) Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment. Obes Surg 23:234-240
21. Navarrete SA, Leyba J, Navarrete LL et al (2012) Roux-en-Y gastric bypass for treatment of patients with DM type 2 and BMI of 30 to 35 kg/m2. Nutr Hosp 27:1160-1165
22. Shah SS, Todkar JS, Shah PS et al (2010) Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis 6:332-338
23. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219
24. Sampalis JS, Liberman M, Auger S et al (2004) The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg 14:939-947
25. Mistry SB, Omana JJ, Kini S (2009) Rat models for bariatric surgery and surgery for type 2 diabetes mellitus. Obes Surg 19:655-660
26. Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1-11
27. Rubino F, Zizzari P, Tomasetto C et al (2005) The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 146:1745-1751
28. Patriti A, Facchiano E, Annetti C et al (2005) Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258-1264
29. Gastrointestinal surgery for severe obesity (1991). National Institutes of Health Consensus Development Conference Statement. NIH Consensus Development Conference; 25-27 March 1991. http://consensus.nih.gov/1991/1991GISurger yObesity084PDF.pdf
30. Angrisani L, Favretti F, Furbetta F et al (2004) Italian group for lap-band system®: results of multicenter study on patients with BMI ≤35 kg/m2. Obes Surg 14:415-418
31. Parikh M, Duncombe J, Fielding GA (2006) Laparoscopic adjustable gastric banding for patients with body mass index of 35 kg/m2. Surg Obes Rel Dis 2:518-522
32. Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta analysis. Am J Med 122:248-256
33. Hall TC, Pellen MG, Sedman PC et al (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20:1245-1250
34. Ferrannini E, Mingrone G et al (2009) Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 32:514-520
35. Flatt PR (2007) Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? Diab Vasc Dis Res 4:151-153
36. Gumbs A, Modlin IM, Ballantyne GH (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 15:462-473
37. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503
38. Ramos AC, Galvao Neto MP, de Souza YM et al (2009) Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg 19:307-312
39. Ferzli GS, Dominique E, Ciaglia M et al (2009) Clinical improvement after duodenojejunal bypass for nonobese Type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 33:972-979
40. Geloneze B, Geloneze SR, Fiori C et al (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 19:1077-1083
41. Chiellini C, Rubino F, Castagneto M et al (2009) The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2. Diabetologia 52:1027-1030
42. Scopinaro N, Papadia F, Marinari G et al (2007) Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg 17:185-192
43. DePaula AL, Macedo ALV, Mota BR et al (2009) Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 23:1313-1320